Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Impact of Dietary Patterns on Prognosis of Ovarian Cancer Patients During PARPi Maintenance
A ClinicalTrials.gov update describes a study evaluating how dietary patterns affect prognosis for ovarian cancer patients during PARP inhib…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
This clinical trial update reports that City of Hope Medical Center's remote telemonitoring study of patient-generated physiological data an…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Contribution of Oncovascular Surgery in the Treatment of Gynecological Advanced Malignant Diseases.
Clinical trial update describing the role of oncovascular surgery in treating advanced gynecologic cancers, sponsored by the National Cancer…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Utility of Adjusting Chemotherapy Dose & Dosing Schedule With the SALVage Weekly Dose-dense Regimen in Patients With Poor Prognostic OVARian Cancers Based on the Tumor Unfavorable Primary Chemosensitivity and Incomplete Debulking Surgery [Phase 3]
Phase 3 clinical trial evaluating whether adjusting chemotherapy dose and the SALVage weekly dose-dense regimen improves outcomes in patient…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: PROADAPT-ovary/EWOC-2 [NA]
Clinical trial PROADAPT-ovary/EWOC-2 (NCT04284969) is a study sponsored by Hospices Civils de Lyon examining treatment strategies for ovaria…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Study Looking at Biomarkers in Ovarian Cancer [NA]
A clinical trial investigating biomarkers in ovarian cancer is currently recruiting. The study is sponsored by University Health Network in …
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer [Phase 2]
A Phase 2 clinical trial evaluating adverse events and changes in disease activity across multiple treatment combinations using mirvetuximab…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors [Phase 1]
Phase 1 study of TBI-1301, an NY-ESO-1–specific TCR gene-transduced autologous T cell therapy, in solid tumors; the trial is currently activ…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers [Phase 1, Phase 2]
Regeneron is conducting a Phase 1/2 trial of REGN4018 (Ubamatamab) alone or in combination with cemiplimab in adults with recurrent MUC16-ex…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations [Phase 2, Phase 3]
The DETERMINE trial update investigates the combination of Trastuzumab and Pertuzumab for HER2-amplified or activating-mutant cancers in adu…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer [Phase 1, Phase 2]
Clinical trial update describing a Phase 1/2 study of sacituzumab govitecan in combination with cisplatin for platinum-sensitive recurrent o…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Contribution of Preserving the Superior Left Colic Artery to the Vascularization of the Descending Colon Prior to Colorectal Anastomosis During Left-Sided or Rectal Resections for Colorectal or Ovarian Cancer. (Revascularisation Colique) [NA]
A clinical trial investigating whether preserving the superior left colic artery improves vascularization of the descending colon prior to c…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors
This ClinicalTrials.gov entry describes a recruiting USC-led study evaluating social health, activity behaviors, and quality of life among y…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: BRCA Mutation Carriers' Platform a Multicenter Study
A multicenter clinical trial platform for BRCA1 and BRCA2 mutation carriers is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer. [Phase 1]
Phase 1 trial update of Naptumomab Estafenatox in combination with durvalumab in selected advanced or metastatic solid tumors, including eso…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Vismodegib Combined With Atezolizumab in Platinum Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer [Phase 2]
A Phase 2 trial investigating the combination of vismodegib and atezolizumab in platinum-resistant ovarian, fallopian tube, and primary peri…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Comprehensive Yoga Therapy Based Lifestyle Prehabilitation Program for Women With Ovarian Cancer [NA]
This clinical trial update describes a comprehensive yoga therapy-based lifestyle prehabilitation program for women with ovarian cancer. The…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas [Phase 2]
Phase 2 study of LN-145 (LN-145-S1) in relapsed or refractory ovarian cancer, triple-negative breast cancer, anaplastic thyroid cancer, oste…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Liposomal Irinotecan Combined With Sintilimab and Anlotinib in the Treatment of Recurrent or Persistent Ovarian Clear Cell Carcinoma [Phase 2]
This is a Phase 2 clinical trial update evaluating liposomal irinotecan in combination with sintilimab and anlotinib for recurrent or persis…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Prediction of Ovarian Cancer Histotypes and Surgical Outcome
This update describes a clinical trial investigating histotype prediction in ovarian cancer and the associated surgical outcomes. The study …
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics. [NA]
MD Anderson Cancer Center is recruiting for a study to identify underserved Texans at hereditary cancer risk using mobile mammography units …
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Detection of Homologous Recombination Pathway Gene Mutations in Circulating Tumour DNA From BRCA-mutated Ovarian Cancer Patients Receiving First-line PARP Inhibitor Maintenance Therapy [NA]
Clinical trial update describing detection of homologous recombination pathway gene mutations in circulating tumor DNA from BRCA-mutated ova…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression [Phase 1, Phase 2]
Clinical trial update for BT5528-100 (Phase 1/2) in EphA2-expressing advanced solid tumors. The study includes urothelial carcinoma, ovarian…
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies [Phase 1, Phase 2]
Clinical trial update for BT8009-100 in nectin-4 expressing advanced malignancies (Phase 1/2) with status ACTIVE_NOT_RECRUITING.
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer [NA]
Clinical trial investigating transvaginal ultrasonography as a screening method for ovarian cancer; the study is currently recruiting.